David Weatherall

Sir David John Weatherall ( born March 9, 1933) is a British molecular geneticists and physicians (hematology, pathology).

Weatherall studied medicine at the University of Liverpool with the conclusion of 1956 ( MD, MB Bachelor of Medicine, Bachelor of Surgery ChB ). He then spent two years in the army (including Nepal ) and a fellowship at the Johns Hopkins University before he returned to the University of Liverpool, where he became professor of hematology. In 1974 he was Nuffield Professor of Clinical Medicine at Oxford University and from 1992 to 2000 he was Regius Professor of Medicine there. In 1989 he founded the Institute for Molecular Medicine in Oxford, which was named after his retirement after him ( Weatherall Institute of Molecular Medicine ). After his retirement in 2000, he was chancellor of Keele University.

Weatherall is a leading expert on thalassemia, a hereditary disease characterized by abnormally altered production of globins. He built since the 1970s on a research network ( for example, Thailand, Laos, Kenya, Vietnam) on thalassemia and could improve their clinical treatment in the developing world where the disease play a special role countries.

In 2002, he was lead author of a report for the WHO on the application of genetic engineering to world health issues.

In 1987 he was knighted. He is active in the British Humanist Association. In 2010 he won the Lasker- Koshland Special Achievement Award in Medical Science (after the eulogy for its leading international role in biomedicine in the last 50 years ), the 2001 Prince Mahidol Award and the 2003 William Allan Award. In 1994 he was awarded the Buchanan Medal of the Royal Society. In 2011 he was awarded the Karl Landsteiner Memorial Award. He is a Fellow of the Royal Society and the Royal College of Physicians.